Maternal-Fetal Medicine
• Prenatal diagnosis
• Prevention of preterm birth
• Drug/chemical exposure in pregnancy

• Washington, 2010

• Active candidate for board certification in Obstetrics and

  Gynecology, 2011-12

7/1/10

• MD degree
  (Drexel University College of Medicine, 2006)
• Residency in Obstetrics and Gynecology
  (Oregon Health & Science University, 2010)
• Fellow, Maternal-Fetal Medicine
  (University of Washington, 2013)

• Infectious disease
• Prenatal ultrasound
• Use of simulation to improve obstetric outcomes

• American Congress of Obstetricians and Gynecologists,

  Junior Fellow
• Society for Maternal-Fetal Medicine
• Physicians for a National Health Program
• American Medical Association

Vanderhoeven JP, Tolosa JE (in press). Ch. 11: Tobacco and Preterm birth. Preterm Birth: Prevention and Management. Ed: V. Berghella. Wiley-Blackwell Publishing.

 

 

Kijak GH, Simon V, Balfe P, Vanderhoeven J, Pampuro SE, Zala C, Ochoa C, Cahn P, Markowitz M, Salomon H. Origin of human immunodeficiency virus type 1 quasispecies emerging after antiretroviral treatment interruption in patients with therapeutic failure. J Virol. 2002 Jul; 76(14):7000-9.

 

Simon V, Padte N, Murray D, Vanderhoeven J, Wrin T, Parkin N, DiMascio M, Markowitz M. Infectivity and replication capacity of drug-resistant human immunodeficiency virus type 1 variants isolated during primary infection. J Virol. 2003 Jul; 77(14):7736-7745.

 

Ramratnam B, Ribeiro R, He T, Chung C, Simon V, Vanderhoeven J, Hurley A, Zhang L, Perelson AS, Ho DD, Markowitz M. Intensification of antiretroviral therapy accelerates the decay of the HIV-1 latent reservoir and decreases, but does not eliminate, ongoing virus replication. J Acquir Immune Defic Syndr. 2004 Jan; 35(1):33-37.

 

Markowitz M, Jin X, Hurley A, Simon V, Ramratnam B, Louie M, Deschenes GR, Ramratnathan M Jr, Barsoum S, Vanderhoeven J, He T, Chung C, Murray J, Perelson AS, Zhang L, Ho DD. Discontinuation of antiretroviral therapy commenced early during the course of human immunodeficiency virus type 1 infection, with or without adjunctive vaccination. J Infect Dis. 2002 Sep; 186(5):634-43.